Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

Satisfaction With Treatment In Patients With Erectile Dysfunction And Cardiovascular Risk And/Or Previous Cardiovascular Event.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00874185

Acronym

TIERRA

Enrollment

720

Registered

2009-04-02

Start date

2007-12-31

Completion date

2008-05-31

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Keywords

satisfaction

Brief summary

Evaluate satisfaction in people treated with IPDE5 inhibitors over time

Detailed description

12 first patients that are eligible

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* CV risk factors * Male above 18

Exclusion criteria

* Non-informed consent

Design outcomes

Primary

Measure	Time frame
EDITS	6 months
SEAR	6 months

Secondary

Measure	Time frame
Medication prescribed	6 months

Outcome results